Harpoon Therapeutics HARP
$ 23.01
0.0%
Quarterly report 2023-Q3
added 11-09-2023
Country |
USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Gerald McMahon |
Employees in the company |
77 |
Shares |
33.2 M |
Market Cap[1] |
$ 763 M |
EBITDA (LTM) |
$ -30.5 M |
P/E (LTM) |
-1.49 |
P/S (LTM) |
4.49 |
EPS (LTM) |
-4.26 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.